{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T22:01:14Z","timestamp":1773612074812,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Neck lymph node metastasis (NLNM) in epithelial ovarian cancer (EOC) is rare and treated as advanced stage cancer. However, ovarian cancer with lymphatic metastasis may manifest a different clinical course from peritoneal carcinomatosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The authors retrospectively assessed 20 patients with EOC and pathologically diagnosed as NLNM between January 2001 and December 2010. The patients were divided into two groups according to the time of NLNM identification. Statistical methods included Kaplan-Meier, log-rank, and Cox regression analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Eleven patients were diagnosed with NLNM at the same time of surgical exploration of EOC (Group A) and nine patients at cancer recurrence 43.3 months after initial surgery (Group B). In Group A, patients with tumors confined to the pelvic cavity had no recurrence or had isolated lymph node recurrence (ILNR), and survived longer than patients with abdominal tumor spreading (<jats:italic>P<\/jats:italic> = 0.0007). In Group B, 2 patients showed ILNR. The median survival time after NLNM was 42 months in Group A and 6 months in Group B (<jats:italic>P<\/jats:italic> = 0.01). Cox model demonstrated that non-serous histology, brain metastasis, and NLNM identified at cancer recurrence were major predictors for poor overall survival (Hazard ratio [HR] = 18.67, 6.93, and 4.52; <jats:italic>P<\/jats:italic> = 0.01, 0.02, and 0.04, respectively).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>A subgroup of EOC patients with NLNM who presented limited pelvic cancer had much better overall survival than patients who had cancer spreading beyond the pelvic cavity or were diagnosed with NLNM at cancer recurrence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7819-11-255","type":"journal-article","created":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T03:01:33Z","timestamp":1380769293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical features and outcomes of neck lymphatic metastasis in ovarian epithelial carcinoma"],"prefix":"10.1186","volume":"11","author":[{"given":"Chien-Wen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pao-Ling","family":"Torng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,3]]},"reference":[{"key":"1927_CR1","doi-asserted-by":"publisher","first-page":"S1534","DOI":"10.1002\/cncr.2820710420","volume":"71","author":"WJ Hoskins","year":"1993","unstructured":"Hoskins WJ: Surgical staging and cytoreductive surgery of epithelial ovarian cancer. Cancer. 1993, 71: S1534-S1540. 10.1002\/cncr.2820710420.","journal-title":"Cancer"},{"key":"1927_CR2","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1111\/IGC.0b013e3181bf8111","volume":"19","author":"JS Berek","year":"2009","unstructured":"Berek JS: Lymph node-positive stage IIIIC ovarian cancer. A separate entity?. Int J Gynecol Cancer. 2009, 19: S18-S20. 10.1111\/IGC.0b013e3181bf8111.","journal-title":"Int J Gynecol Cancer"},{"key":"1927_CR3","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1555::AID-CNCR10>3.0.CO;2-R","volume":"83","author":"T Onda","year":"1998","unstructured":"Onda T, Yoshikawa H, Yasugi T, Mishima M, Nakagawa S, Yamada M, Matsumoto K, Taketani Y: Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to stage I\/II patients and superior survival to other stage III patients. Cancer. 1998, 83: 1555-1560. 10.1002\/(SICI)1097-0142(19981015)83:8<1555::AID-CNCR10>3.0.CO;2-R.","journal-title":"Cancer"},{"key":"1927_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1006\/gyno.1999.5349","volume":"73","author":"K Kanazawa","year":"1999","unstructured":"Kanazawa K, Suzuki T, Tokashiki M: The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival. Gyn Oncol. 1999, 73: 237-241. 10.1006\/gyno.1999.5349.","journal-title":"Gyn Oncol"},{"key":"1927_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ygyno.2006.08.047","volume":"103","author":"WA Cliby","year":"2006","unstructured":"Cliby WA, Aletti GD, Wilson TO, Podratz KC: Is it justified to classify patients to stage IIIC epithelial ovarian cancer based on nodal involvement only?. Gynecol Oncol. 2006, 103: 797-801. 10.1016\/j.ygyno.2006.08.047.","journal-title":"Gynecol Oncol"},{"key":"1927_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ygyno.2007.05.016","volume":"107","author":"G Ferrandina","year":"2007","unstructured":"Ferrandina G, Scambia G, Legge F, Petrillo M, Salutari V: Ovarian cancer patients with node-positive only stage IIIC disease have a more favorable outcome than stage IIIa\/b. Gynecol Oncol. 2007, 107: 154-156. 10.1016\/j.ygyno.2007.05.016.","journal-title":"Gynecol Oncol"},{"key":"1927_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1471-2407-8-367","volume":"8","author":"F Legge","year":"2008","unstructured":"Legge F, Petrillo M, Adamo V, Pisconti S, Scambia G, Ferrandina G: Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome. BMC Cancer. 2008, 8: 367-10.1186\/1471-2407-8-367.","journal-title":"BMC Cancer"},{"key":"1927_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ygyno.2006.06.039","volume":"104","author":"P Blanchard","year":"2007","unstructured":"Blanchard P, Plantade A, Pages C, Afchain P, Louvet C, Tournigand C, de Gramont A: Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors. Gynecol Oncol. 2007, 104: 41-45. 10.1016\/j.ygyno.2006.06.039.","journal-title":"Gynecol Oncol"},{"key":"1927_CR9","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1245\/ASO.2004.11.023","volume":"11","author":"C Uzan","year":"2004","unstructured":"Uzan C, Morice P, Rey A, Pautier P, Camatte S, Lhomm\u00e9 C, Haie-Meder C, Duvillard P, Castaigne D: Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes. Ann Surg Oncol. 2004, 11: 658-664. 10.1245\/ASO.2004.11.023.","journal-title":"Ann Surg Oncol"},{"key":"1927_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ygyno.2006.10.020","volume":"104","author":"A Santillan","year":"2007","unstructured":"Santillan A, Karam AK, Li AJ, Giuntoli R, Gardner GJ, Cass I, Karlan BY, Bristow RE: Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer. Gynecol Oncol. 2007, 104: 686-690. 10.1016\/j.ygyno.2006.10.020.","journal-title":"Gynecol Oncol"},{"key":"1927_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ygyno.2009.04.025","volume":"114","author":"S Fotiou","year":"2009","unstructured":"Fotiou S, Aliki T, Petros Z, Ioanna S, Konstantinos V, Vasiliki M, George C: Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer. Gynecol Oncol. 2009, 114: 178-182. 10.1016\/j.ygyno.2009.04.025.","journal-title":"Gynecol Oncol"},{"key":"1927_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ygyno.2009.11.008","volume":"116","author":"A Gadducci","year":"2010","unstructured":"Gadducci A, Cosio S, Zola P, Sostegni B, Ferrero AM, Teti G, Cristofani R, Sartori E: The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study. Gynecol Oncol. 2010, 116: 358-363. 10.1016\/j.ygyno.2009.11.008.","journal-title":"Gynecol Oncol"},{"key":"1927_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1148\/radiology.215.3.r00jn25761","volume":"215","author":"CM Tempany","year":"2000","unstructured":"Tempany CM, Zou KH, Silverman SG, Brown DL, Kurtz AB, McNeil BJ: Staging of advanced ovarian cancer: comparison of imaging modalities\u2013report from the Radiological Diagnostic Oncology Group. Radiology. 2000, 215: 761-767.","journal-title":"Radiology"},{"key":"1927_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ygyno.2009.10.059","volume":"116","author":"EJ Nam","year":"2010","unstructured":"Nam EJ, Yun MJ, Oh YT, Kim JW, Kim JH, Kim S, Jung YW, Kim SW, Kim YT: Diagnosis and staging of primary ovarian cancer: correlation between PET\/CT, Doppler US, and CT or MRI. Gynecol Oncol. 2010, 116: 389-394. 10.1016\/j.ygyno.2009.10.059.","journal-title":"Gynecol Oncol"},{"key":"1927_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ygyno.2011.09.013","volume":"123","author":"M Kleppe","year":"2011","unstructured":"Kleppe M, Wang T, Van Gorp T, Slangen BF, Kruse AJ, Kruitwagen RF: Lymph node metastasis in stages I and II ovarian cancer: a review. Gynecol Oncol. 2011, 123: 610-614. 10.1016\/j.ygyno.2011.09.013.","journal-title":"Gynecol Oncol"},{"key":"1927_CR16","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ygyno.2011.05.001","volume":"122","author":"CA Powless","year":"2011","unstructured":"Powless CA, Aletti GD, Bakkum-Gamez JN, Bakkum-Gamez JN, Cliby WA: Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging. Gynecol Oncol. 2011, 122: 536-540. 10.1016\/j.ygyno.2011.05.001.","journal-title":"Gynecol Oncol"},{"key":"1927_CR17","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/annonc\/mdq229","volume":"21","author":"J Sehouli","year":"2010","unstructured":"Sehouli J, Pietzner K, Harter P, M\u00fcnstedt K, Mahner S, Hasenburg A, Camara O, Wimberger P, Boehmer D, Buehling KJ, Richter R, El Khalfaoui K, Oskay-Ozcelik G: Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study. Ann Oncol. 2010, 21: 2201-2205. 10.1093\/annonc\/mdq229.","journal-title":"Ann Oncol"},{"key":"1927_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1365-2354.2009.01133.x","volume":"20","author":"YL Chen","year":"2011","unstructured":"Chen YL, Cheng WF, Hsieh CY, Chen CA: Brain metastasis as a late manifestation of ovarian carcinoma. Eur J Cancer Care. 2011, 20: 44-49. 10.1111\/j.1365-2354.2009.01133.x.","journal-title":"Eur J Cancer Care"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-11-255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T19:07:45Z","timestamp":1630609665000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-11-255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1927"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-11-255","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,3]]},"assertion":[{"value":"17 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"255"}}